购物车
- 全部删除
- 您的购物车当前为空
Crisaborole (AN-2728) 是一种有效的 PDE4和 cytokine 释放抑制剂,能够抑制 PDE4(IC50=0.49 μM)。
Crisaborole (AN-2728) 是一种有效的 PDE4和 cytokine 释放抑制剂,能够抑制 PDE4(IC50=0.49 μM)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 229 | 现货 | |
10 mg | ¥ 373 | 现货 | |
50 mg | ¥ 591 | 现货 | |
100 mg | ¥ 792 | 现货 | |
200 mg | ¥ 996 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 415 | 现货 |
产品描述 | Crisaborole (AN-2728) is a Phosphodiesterase 4 Inhibitor. |
靶点活性 | PDE4:0.49 μM |
体外活性 | AN-2728 inhibits PDE isozymes PDE1A3, PDE3Cat , PDE4Cat and PDE7A1 with IC50 values of 6.1, 6.4, 0.11 and 0.73 μM. AN-2728 inhibits PDE4, TNF-α, IL-2, IFN-γ, IL-5 and IL-10 with IC50 values of 0.49, 0.54, 0.61, 0.83, 2.4 and 5.3 μM. AN-2728 shows the most potent activity against PDE4 catalytic domain, but it also shows inhibition against PDE1A3, PDE3Cat, and PDE7A1. Crystallography reveals that interaction of benzoxaboroles with the hydrophobic pocket in the PDE4 catalytic domain increase their affinity for PDE4. These benzoxaboroles strongly suppresses the secretion of cytokines associated with Ps and AD. |
体内活性 | AN-2728 is reported to be well tolerated and to demonstrate significant effects on markers of efficacy, with results that were comparable to positive controls in clinical trials. AN-2728 shows significant inhibition against the ear edema caused by phorbol ester after dosing at 1 mg/ear×2 (78% and 68%, respectively). The efficacy is comparable to that of dexamethasone, suggesting that AN-2728 has good anti-inflammatory activity as well as skin penetration. |
别名 | 克立硼罗, AN-2728, PF-06930164 |
分子量 | 251.05 |
分子式 | C14H10BNO3 |
CAS No. | 906673-24-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (199.16 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.